Catalyst Wire Dossier Catalyst Wire Dossier

Bevacizumab-biosimilar (RPH-001)

Bevacizumab biosimilar · TRPHARM
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bevacizumab-biosimilar (RPH-001), covering 2018-04-12 to 2018-04-12. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence and Safety Study of Bevacizumab-biosimilar (RPH-001) Compared to Bevacizumab-innovator [Phase 1]

See pricing